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Abstract
Introduction: Marijuana is a commonly used drug in the United States. Many states
have legalized the recreational use of marijuana. The effects of marijuana on mental
health are unknown.
Methods: In this prospective survey study, eligible participants included ED patients
age 18 and older, who had ever used recreational marijuana. A survey instrument was
developed, piloted, and revised. Data collected included reasons for marijuana use,
marijuana’s perceived effectiveness, and history of mental health conditions, including
depression, anxiety, and suicidal thoughts.
Results: Among 303 participants (86% response rate), the median age of first marijuana
use was 16 ([IQR 14, 19], range 6–65). The most commonly cited reasons for marijuana
use included recreational use (70%; n = 211), to treat anxiety (30%; n = 89), to treat
pain (25%; n = 74), and to treat depression (17%; n = 51). Mental health issues were
common in the study population. A majority of patients reported anxiety in the last
30 days (59%; n = 176), and a significant minority of patients reported serious depression in the last 30 days (46%; n = 137). Some patients reported suicidal thoughts in the
last 30 days (9%; n = 29). Participants who used marijuana more frequently reported
more days of anxiety (median 15.5, compared to 1; P = 0.001). Among participants with
mental health conditions, most began using marijuana before the onset of the mental
health conditions (77%, n = 167). Earlier age of starting to use marijuana was correlated
with higher number of years of anxiety or tension in lifetime (r = −0.11, P = 0.05, n =
301). Perceived effects of marijuana use on mental health were variable. Most participants stated that marijuana improved their mental health (62%; n = 163), and some
reported that marijuana did not improve their mental health (37%; n = 98).
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Conclusions: Many ED patients have used marijuana, either currently or in the past.
Mental health conditions are also common, including anxiety, depression, and suicidal
thoughts. Most participants reported marijuana use starting at an age under 18. Marijuana use preceded the onset of mental health conditions in the majority of participants.

1

INTRODUCTION

anorexia-associated weight loss in patients with HIV/AIDS.10 However,
marijuana can also cause nausea and vomiting.11 It has recently been

1.1

Background

demonstrated that the prevalence of cannabis hyperemesis syndrome
has been increasing in EDs since medical marijuana liberalization.12

Marijuana is an increasingly common recreational drug in the United

The syndrome usually occurs in relation to chronic marijuana use but

States. An estimated 43.5 million people used marijuana in 2018, mak-

can also be seen with sporadic use.13

ing it the most commonly used federally illegal drug in the United

Many studies have shown adverse neurologic effects of acute and

States. According to the 2018 National Survey on Drug Use and Health,

long-term regular cannabis use.14-16 In utero exposure has been linked

almost half (48%) of American adults have used marijuana at least once

to permanent neurobehavioral and cognitive impairments.17 In chil-

in their lifetime, with 11% indicating use within the past month. Rates

dren acutely exposed to marijuana in sufficient quantities, severe cen-

of marijuana use tend to be higher among men (53%) than women

tral nervous system depression can present as profound depression,

(44%), and as age increases, a decline in use is observed.1 Individu-

lethargy, and coma.8 In addition, cannabis use has been associated with

als suffering from medical conditions, including mental health illnesses,

an increased risk of psychosis and earlier onset of psychosis in those

report using marijuana more than healthy people, leading to ques-

who use daily and high-potency cannabis.9 It has also been shown

tions regarding marijuana’s perceived role in ameliorating symptoms of

to interfere with executive cognitive functions acutely and for days

disease.1,2 Many Americans believe that marijuana is a viable therapeu-

after.10 Some studies have even demonstrated an association between

tic option for pain management, the treatment of chronic conditions,

marijuana use and impaired short- and long-term driving ability.18,19

and relief from mental health symptoms. Furthermore, approximately

Marijuana use has also been linked to a significantly increased risk of

one-third of Americans agree that marijuana has preventive qualities

motor vehicle accidents.20 There is little published data that define the

when it comes to these health

conditions.3

In 2011, the Drug Abuse

Warning Network (DAWN) reported that out of all drug-related emer-

physiologic effects of marijuana on depression, anxiety, and other mental health conditions.

gency department visits, marijuana was implicated in roughly 456,000
visits, second only to cocaine use.4
Public attitude toward recreational use of marijuana has shifted in

1.3

Goals of this study

the recent past as a result of period effects including the liberalization
of policy,5 and support for the legalization of marijuana by Americans

This study was undertaken to identify any relationship between mari-

is growing.5,6 Although marijuana remains illegal under federal legisla-

juana use and mental health among ED patients.

tion and retains a Schedule I classification, as of 2019, 11 states and
Washington D.C. have approved its use for recreational purposes, and
33 states and Washington D.C. have public medical cannabis programs.

2

METHODS

Following this trend, 26 states and Washington D.C. have decriminalized the possession of small amounts of marijuana.7

2.1

Design and setting

This was a prospective survey study conducted at Miami Valley Hos-

1.2

Importance

pital, an inner-city Level 1 Trauma Center with an annual volume of
95,000. The study was approved by the Wright State University Insti-

Marijuana has been associated with numerous clinical effects. Short-

tutional Review Board.

term intoxication side effects include confusion, dizziness, disorientation, hallucination, euphoria, agitation, and dry mouth.8,9 Marijuana
has been shown to stimulate appetite. For this reason, the synthetic

2.2

Selection of subjects

tetrahydrocannabinol (THC) cannabinoid analogues dronabinol and
nabilone have been approved by the Food and Drug Administration

Eligible participants included ED patients age 18 and over, who had

(FDA) for the treatment of chemotherapy-induced nausea and vom-

ever used marijuana. Consecutive patients were approached as a con-

iting. Dronabinol has also been FDA-approved for the treatment of

venience sample when a research assistant was available, during the
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time period May to September 2019. Patients who did not speak
English, were in distress, or declined to participate were excluded. Sub-

The Bottom Line

jects were approached with an invitation to participate while in the

As marijuana is becoming more legalized in various states in

ED treatment area. Subject participation did not interfere with medi-

the United States, many Americans use marijuana as a ther-

cal care or interrupt its delivery, and protected health information was

apeutic option for pain and relief from mental health symp-

not recorded.

toms. This prospective study investigates the effect of marijuana on mental health and was found that marijuana use
often preceded the onset of mental health conditions.

2.3

Exposures

The study design and the survey instrument were developed by a panel
of emergency physicians and the Wright State University, Department

between the age of first marijuana use and days of depression in the

of Emergency Medicine Research Committee, composed of emergency

past 30 days.

medicine faculty and residents. Questions regarding marijuana use and

Marijuana use in the last 30 days varied among participants, both in

mental health were based on items in the Addiction Severity Index, a

the number of days used and the total number of times used. The major-

validated measurement tool to objectively assess addiction.21,22 The

ity, 183 (60.8%), reported no marijuana use in the last 30 days. Forty-

survey instrument was piloted among eligible ED patients and modified

one (13.6%) patients used marijuana 1–5 days, 36 (12.0%) used it 6–19

for clarity and readability.

days, and 41 (13.6%) used it 20–30 days, which included 32 patients

Data collected included: marijuana use in the last 30 days, age of

using marijuana every day of the last 30. The most commonly reported

first use, most recent use to time of survey, reasons for use, effective-

route of use of marijuana was smoking (98%; n = 297), edibles (17%,

ness on reasons for use, previous history of psychiatric care, the pres-

n = 51), and other (2%; n = 7).

ence of anxiety, depression and suicidal thoughts, and whether mari-

The most commonly cited reasons for marijuana use included recre-

juana use improves or worsens the subject’s mental health. Reasons for

ational use (705; n = 211), to treat anxiety (30%; n = 89), to treat pain

marijuana use were the primary outcome measure. A pre-hoc sample

(25%; n = 74), and to treat depression (17%; n = 51). Perceived effec-

size calculation demonstrated that a sample size of 96 was needed to

tiveness of these effects is shown in Table 2.

establish a 95% confidence interval of ±10% for the primary outcome
measure, reason for marijuana use. Additional subjects were recruited
to increase the study’s power.

2.4

Analysis

TA B L E 1
questions

Descriptive statistics for all quantitative survey

No. respondents

303

Patient age (y)

45 [32, 56]
range 18–88

Spearman correlation coefficient was used to examine relationships
between marijuana use and mental health. Differences between
remote and current marijuana users were tested with Mann-Whitney
Wilcoxon tests. Differences among mental health by frequency of marijuana use were tested with Kruskal-Wallis tests. P values <0.05 were
considered statistically significant.

3

RESULTS

Among 352 eligible participants, 303 consented to participate (86%

Patient sex
Male

145 (47.9%)

Female

158 (52.2%)

Ethnicity
African-American
Asian

0 (0%)

White

167 (55.1%)

Hispanic

5 (1.7%)

Multiracial

4 (1.3%)

Mode of arrival in ED

participation rate). Among participants, 145 (48%) were males and 158

Walk-in

(52%) were females, with a mean age of 45 (range of 18–88). The most

Ambulance

common ethnicities were White (55%) and African-American (42%)
(Table 1).
The median age of first marijuana use was 16 ([IQR 14, 19], range
6–65). Age of first use was not significantly associated with years of
serious depression (r = −0.08, P = 0.16, n = 301) nor with years of serious thoughts of suicide (r = −0.03, P = 0.65, n = 296). Age of first use
was negatively correlated with years experienced serious anxiety or
tension (r = −0.11, P = 0.05, n = 301). No correlations were detected

127 (41.9%)

209 (69.2%)
93 (30.8%)

Triage level
1

0 (0%)

2

70 (23.4%)

3

186 (62.2%)

4

42 (14.1%)

5

1 (0.3%)

Data are presented as frequency count (%) or median [interquartile range].
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TA B L E 2

Perceived efficacy of marijuanaa

“Does marijuana help you with
this reason?”

1: no
help (%)

2: little
help (%)

3: moderate
(%)

4: helps a
lot (%)

5: great deal
of help (%)

Recreational (n = 212)

52 (24.5)

11 (5.2)

34 (16.0)

31 (14.6)

84 (39.6)

To treat pain (n = 73)

3 (4.1)

2 (2.8)

4 (5.5)

18 (24.7)

46 (63.0)

To treat depression (n = 53)

1 (1.9)

2 (3.8)

2 (3.8)

12 (22.6)

36 (67.9)

To treat anxiety (n = 90)

1 (1.1)

6 (6.7)

7 (7.8)

14 (15.6)

62 (68.9)

To treat sleep disorder (n = 32)

1 (3.1)

0 (0)

2 (6.3)

2 (6.3)

27 (84.4)

Other (n = 64)

1 (1.6)

2 (3.1)

6 (9.4)

8 (12.5)

47 (73.4)

a Participants responses to the question: “Does marijuana help you with this reason?”

TA B L E 3

Comparison of timing of first use of marijuana with estimated onset of mental health issues
Mental health issue

Comparison of age of first use of marijuana with estimated
age mental health issue began

Depression
(%)

Anxiety
(%)

Suicidal
thoughts (%)

No. of patients with mental health issue (years in lifetime >0)

216 (71)

218 (72)

124 (41)

Marijuana use started before mental health issue

167 (77.3)

159 (72.9)

113 (91.1)

Mental health issue started before marijuana use

43 (19.9)

52 (23.9)

8 (6.5)

6 (2.8)

7 (3.2)

3 (2.4)

Marijuana use started same year as mental health issue

Mental health conditions were common in the study population. A

5

DISCUSSION

majority of patients reported anxiety in the last 30 days (59%; n = 176),
and a significant minority of patients reported serious depression in the

As a result of increasing access, due to both medical use and recre-

last 30 days (46%; n = 137). Some patients reported suicidal thoughts

ational legalization, marijuana use has increased dramatically in the

in the last 30 days (9%; n = 29). Participants who used marijuana more

United States.23 However, the ramifications of this increased exposure

frequently reported more days of anxiety (median 15.5, compared to 1;

to the known psychoactive compounds present in marijuana are poorly

P = 0.001).

understood. Cannabis is a heterogeneous mix of multiple psychoactive

Among participants with mental health conditions, most began

compounds, but the most extensively studied and prevalent are

using marijuana before the onset of the mental health conditions (77%,

cannabidiol and Δ-THC, which elicit psychoactive effects through

n = 167) (Table 3). Earlier age of starting to use marijuana was cor-

interaction with the endocannabinoid system.24 Effects on cognitive

related with higher number of years of anxiety or tension in lifetime

function have been evaluated in a number of studies and recently

(r = −0.11, P = 0.05, n = 301). Perceived effects of marijuana use on

summarized to demonstrate both acute and chronic declines in verbal

mental health were variable. Most participants stated that marijuana

learning and memory, impaired attention, and psychomotor function.

improved their mental health (62%; n = 163), and some reported that

There does appear to be a dose-dependent effect, with higher fre-

marijuana did not improve their mental health (37%; n = 98). Free text

quency and higher THC potency resulting in more profound deficits.

comments regarding effects of marijuana are summarized in Table 4.

It is as yet unclear whether some or all of these functions recover

Participants were offered consultation with Social Services for drug
treatment. A minority (8%; n = 25) accepted this invitation.

after a period of prolonged abstinence. One study following prolonged
exposure to THC from childhood through midlife found a 6-point
decline in IQ points relative to non-marijuana users.25
In addition to cognitive effects, marijuana use has long been associ-

4

LIMITATIONS

ated with increased frequency of psychosis and associated behaviors.
In a large European study, a strong effect of daily use of high potency

This study was conducted at a single institution and results may not

cannabis preparation was associated with 12% of first case psychosis

be generalizable to other settings. Data were self-reported, and the

events across Europe. Targeted populations in London and Amster-

accuracy of the data is dependent on the accuracy of participant self-

dam were found to have a 30% and 50% incidence, respectively, of

reports. It is possible that participants did not accurately diagnose the

heavy cannabis-associated psychosis.26 Those who had started using

onset of mental health conditions. Although we identified a temporal

high potency cannabis by age 15 years showed a doubling of risk.

relationship between marijuana use, which commonly preceded treat-

This study identified a young age of first marijuana use (median 16,

ment for mental health, we cannot infer a causal relationship. Although

range 6–65). This finding is of concern, given a growing body of liter-

many patients reported anxiety, the relationship of marijuana with the

ature of the cognitive and emotional effects of marijuana on children

incidence of anxiety is unknown.

and adolescents. A recent meta-analysis study identified increased
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TA B L E 4
Explain.”

a

Responses to question: “Is there a relationship between marijuana use and the way you feel? This may include depression or anxiety.

Perceived positive effects of
marijuana

n

%a

Perceived negative effects
of marijuana

n

%a

Relaxes/calms me/reduce stress

65

21

Worsens focus/cannot think

11

4

Happiness/feels good

36

12

Worsen anxiety

9

3

Improve anxiety

24

8

Worsen paranoia

4

1

Improve depression

17

6

Worsen depression

3

1

Escape from problems/reality

17

6

Worsens guilt

1

<1

Improves performance/helps
me think/focus

11

4

Increase hunger

9

3

Get high/intoxication

8

3

Improve pain

8

3

Improve sleep

8

3

Improves sociability

5

2

No effect

116

38

Percent of total participants; may be artificially low because of many participants who did not comment.

rates of major depression and suicidal ideation in young adult users of
marijuana.27

These data add to the body of literature of the relationship of men-

Several studies have indicated a link between adolescent

tal health and marijuana use. The young age of starting marijuana use

cannabis use and the subsequent development of addictions to cocaine

(age 6 and up) should prompt education regarding the adverse effects

and alcohol.28

of marijuana on the developing brain. Future research should aim to

The most commonly cited reasons for marijuana use in this study
included recreational use, treatment for anxiety, pain, and depression.

better elucidate physiologic mechanisms of marijuana and its effects
on mental health conditions.

Many participants believe there is a perceived benefit of treatment

In conclusion, many ED patients have used marijuana, either cur-

for these conditions. This may be due to physiologic effect, anxiolytic

rently or in the past. Mental health conditions are also common,

effect, cognitive effect, or placebo effect. There are limited published

including anxiety, depression, and suicidal thoughts. Most participants

data regarding the physiologic benefit of marijuana in treating mental

reported marijuana use starting at an age under 18. Marijuana use

health conditions, such as depression and anxiety.29-31

preceded the onset of mental health conditions in the majority of

Among participants with mental health conditions, most began

participants.

using marijuana before the onset of the mental health conditions.
This study identified a high incidence of self-reported serious anxi-
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